291 related articles for article (PubMed ID: 32786942)
1. Eliciting Immunogenic Cell Death via a Unitized Nanoinducer.
Dai Z; Tang J; Gu Z; Wang Y; Yang Y; Yang Y; Yu C
Nano Lett; 2020 Sep; 20(9):6246-6254. PubMed ID: 32786942
[TBL] [Abstract][Full Text] [Related]
2. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy.
Feng X; Lin T; Chen D; Li Z; Yang Q; Tian H; Xiao Y; Lin M; Liang M; Guo W; Zhao P; Guo Z
Acta Biomater; 2023 Apr; 160():211-224. PubMed ID: 36792045
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic cell death in cancer therapy: Present and emerging inducers.
Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
[TBL] [Abstract][Full Text] [Related]
5. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
6. Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP.
Xiong X; Huang KB; Wang Y; Cao B; Luo Y; Chen H; Yang Y; Long Y; Liu M; Chan ASC; Liang H; Zou T
J Am Chem Soc; 2022 Jun; 144(23):10407-10416. PubMed ID: 35658433
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
[TBL] [Abstract][Full Text] [Related]
8. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
10. Biomaterials That Induce Immunogenic Cell Death.
Li D; Liu S; Ma Y; Liu S; Liu Y; Ding J
Small Methods; 2023 May; 7(5):e2300204. PubMed ID: 37116170
[TBL] [Abstract][Full Text] [Related]
11. ROS-triggered nanoinducer based on dermatan sulfate enhances immunogenic cell death in melanoma.
Zhang Q; Li S; Ren J; He X; Shi H; Zhang F; Li H; Tong R
J Control Release; 2022 Aug; 348():22-33. PubMed ID: 35461966
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Stress Amplifiers as Immunogenic Cell Death Nanoinducers Disrupting Mitochondrial Redox Homeostasis for Cancer Immunotherapy.
Wan J; Zhang X; Li Z; Mo F; Tang D; Xiao H; Wang J; Rong G; Liu T
Adv Healthc Mater; 2023 Apr; 12(9):e2202710. PubMed ID: 36527737
[TBL] [Abstract][Full Text] [Related]
13. Anticancer metal drugs and immunogenic cell death.
Terenzi A; Pirker C; Keppler BK; Berger W
J Inorg Biochem; 2016 Dec; 165():71-79. PubMed ID: 27350082
[TBL] [Abstract][Full Text] [Related]
14. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.
Yan C; Zhao Y; Liu X; Jiang Y; Li Q; Yang L; Li X; Luo K
ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38915234
[TBL] [Abstract][Full Text] [Related]
15. Self-immolative polymer-based immunogenic cell death inducer for regulation of redox homeostasis.
Jeon J; Yoon B; Dey A; Song SH; Li Y; Joo H; Park JH
Biomaterials; 2023 Apr; 295():122064. PubMed ID: 36827894
[TBL] [Abstract][Full Text] [Related]
16. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis/Necroptosis Inducing Thiazole-Containing Artificial Polypeptide for Immunogenic Cell Death of Cancer.
Park JH; Kim MS; Yun DH; Kim YC
ACS Appl Bio Mater; 2023 Dec; 6(12):5290-5300. PubMed ID: 38044569
[TBL] [Abstract][Full Text] [Related]
18. Polypeptide-Based K
Lee D; Ha J; Ahn H; Jeong SD; Jeong M; Park JH; Yun CO; Kim YC
ACS Appl Bio Mater; 2021 Dec; 4(12):8333-8342. PubMed ID: 35005917
[TBL] [Abstract][Full Text] [Related]
19. Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy.
Zhang F; Chen F; Yang C; Wang L; Hu H; Li X; Zheng X; Wang Z; Chang Z; Li T; Li L; Ge M; Du J; Sun W; Dong WF; Shao D
Small; 2021 Jul; 17(26):e2100006. PubMed ID: 34081391
[TBL] [Abstract][Full Text] [Related]
20. Natural modulators of the hallmarks of immunogenic cell death.
Radogna F; Dicato M; Diederich M
Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
